Show simple item record

dc.contributor.authorAlves Martinez, Pilar
dc.contributor.authorGarcía Alloza, Mónica 
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2024-06-14T09:03:46Z
dc.date.available2024-06-14T09:03:46Z
dc.date.issued2023
dc.identifier.issn1876-7958
dc.identifier.issn1673-5374
dc.identifier.urihttp://hdl.handle.net/10498/32571
dc.description.abstractThere are around 15 million preterm newborns (PT) every year (Atienza-Navarro et al., 2020).es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherWolters Kluwer Medknow Publicationses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceNeural Regeneration Research - 2023, Vol. 18 n. 9 pp. 1942-1943es_ES
dc.titleEffect of caffeine in the intraventricular hemorrhage of the preterm newbornes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.4103/1673-5374.363830
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2020-115499RB-I00/ES/COMPLICACIONES TEMPRANAS EN LA ENFERMEDAD DE ALZHEIMER Y EN DIABETES MELLITUS TIPO 2: IMPLICACIONES FARMACOLOGICAS/ es_ES
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional